Entheon Biomedical Corp Stock Market Value

ENTBF Stock  USD 0.12  0.03  33.33%   
Entheon Biomedical's market value is the price at which a share of Entheon Biomedical trades on a public exchange. It measures the collective expectations of Entheon Biomedical Corp investors about its performance. Entheon Biomedical is trading at 0.12 as of the 15th of December 2024. This is a 33.33% increase since the beginning of the trading day. The stock's lowest day price was 0.12.
With this module, you can estimate the performance of a buy and hold strategy of Entheon Biomedical Corp and determine expected loss or profit from investing in Entheon Biomedical over a given investment horizon. Check out Entheon Biomedical Correlation, Entheon Biomedical Volatility and Entheon Biomedical Alpha and Beta module to complement your research on Entheon Biomedical.
Symbol

Please note, there is a significant difference between Entheon Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Entheon Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Entheon Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Entheon Biomedical 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Entheon Biomedical's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Entheon Biomedical.
0.00
10/16/2024
No Change 0.00  0.0 
In 2 months and 2 days
12/15/2024
0.00
If you would invest  0.00  in Entheon Biomedical on October 16, 2024 and sell it all today you would earn a total of 0.00 from holding Entheon Biomedical Corp or generate 0.0% return on investment in Entheon Biomedical over 60 days. Entheon Biomedical is related to or competes with Sino Biopharmaceutica, Defence Therapeutics, Aileron Therapeutics, and Enlivex Therapeutics. Entheon Biomedical Corp. operates as a biotechnology research and drug development company More

Entheon Biomedical Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Entheon Biomedical's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Entheon Biomedical Corp upside and downside potential and time the market with a certain degree of confidence.

Entheon Biomedical Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Entheon Biomedical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Entheon Biomedical's standard deviation. In reality, there are many statistical measures that can use Entheon Biomedical historical prices to predict the future Entheon Biomedical's volatility.
Hype
Prediction
LowEstimatedHigh
0.010.1235.17
Details
Intrinsic
Valuation
LowRealHigh
0.000.135.15
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Entheon Biomedical. Your research has to be compared to or analyzed against Entheon Biomedical's peers to derive any actionable benefits. When done correctly, Entheon Biomedical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Entheon Biomedical Corp.

Entheon Biomedical Corp Backtested Returns

Entheon Biomedical is out of control given 3 months investment horizon. Entheon Biomedical Corp secures Sharpe Ratio (or Efficiency) of 0.12, which denotes the company had a 0.12% return per unit of risk over the last 3 months. We have analyzed twenty-seven different technical indicators, which can help you to evaluate if expected returns of 4.34% are justified by taking the suggested risk. Use Entheon Biomedical Mean Deviation of 17.61, coefficient of variation of 813.67, and Downside Deviation of 23.76 to evaluate company specific risk that cannot be diversified away. Entheon Biomedical holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 2.37, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Entheon Biomedical will likely underperform. Use Entheon Biomedical treynor ratio, expected short fall, day typical price, as well as the relationship between the potential upside and daily balance of power , to analyze future returns on Entheon Biomedical.

Auto-correlation

    
  -0.19  

Insignificant reverse predictability

Entheon Biomedical Corp has insignificant reverse predictability. Overlapping area represents the amount of predictability between Entheon Biomedical time series from 16th of October 2024 to 15th of November 2024 and 15th of November 2024 to 15th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Entheon Biomedical Corp price movement. The serial correlation of -0.19 indicates that over 19.0% of current Entheon Biomedical price fluctuation can be explain by its past prices.
Correlation Coefficient-0.19
Spearman Rank Test-0.28
Residual Average0.0
Price Variance0.0

Entheon Biomedical Corp lagged returns against current returns

Autocorrelation, which is Entheon Biomedical otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Entheon Biomedical's otc stock expected returns. We can calculate the autocorrelation of Entheon Biomedical returns to help us make a trade decision. For example, suppose you find that Entheon Biomedical has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Entheon Biomedical regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Entheon Biomedical otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Entheon Biomedical otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Entheon Biomedical otc stock over time.
   Current vs Lagged Prices   
       Timeline  

Entheon Biomedical Lagged Returns

When evaluating Entheon Biomedical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Entheon Biomedical otc stock have on its future price. Entheon Biomedical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Entheon Biomedical autocorrelation shows the relationship between Entheon Biomedical otc stock current value and its past values and can show if there is a momentum factor associated with investing in Entheon Biomedical Corp.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in Entheon OTC Stock

Entheon Biomedical financial ratios help investors to determine whether Entheon OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Entheon with respect to the benefits of owning Entheon Biomedical security.